Category Matches
- 5-a-reductase Inhibitors
- 5-Lipoxygenase Inhibitors
- 5-α-Reductase Inhibitors
- a-Glucosidase Inhibitors
- ACE Inhibitors
- Adenosine Receptors - Antiepileptics and Anticonvulsants
- Adrenal Hormones and Modulators
- Adrenergic Receptors - Antiepileptics and Anticonvulsants
- Aldosterone and ENaC Antagonists (K+ Sparing diuretics)
- Amphibian peptides and Hormones
- Analgesics and Antinociceptives
- Androgen Receptor Modulators
- Androgen Synthesis Inhibitors
- Androgens
- andrographolide
- Angiotensin II Inhibitors
- Anti-ulceratives and Antacids
- Antiandrogens
- Antiepileptics and Anticonvulsants
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Antimicrobial Peptides - Others
- Aromatase Inhibitors - Anticancer
- Aromatase Inhibitors - Immunology
- Arthropod peptides and Hormones
- Blog Post
- BYL719
- Ca2+ Channels - Antiepileptics and Anticonvulsants
- Carcinogens and Mutagens
- CCK Release Inhibitors
- Class V (Other)
- Compounds targeting DNA synthesis and repair
- Corticosteroids and Modulators
- CYP17A1 Inhibitors
- Dabrafenib
- dabrafenib
- Dihydrofolate Reductase Inhibitors
- DNA and RNA Synthesis Inhibitors
- DNA Crosslinking and Alkylating Agents
- DNA Strand Break-Inducing Agents
- Dopamine Receptor Inhibitors
- DPP-4 Inhibitors
- Eicosanoid Inhibitors
- Endocrine Signaling and Immunology
- Ergosterol Inhibitors
- Essential vitamins and nutrients
- Estrogen Receptor Inhibitors
- Factor Xa Inhibitors
- Furans - Other nucleic acid inhibitors
- GABA - Antiepileptics and Anticonvulsants
- Ginkgolides and other Ginkgo-related Compounds
- Ginsenosides and Other Ginseng-related Compounds
- Glucocorticoids - Other Therapies
- HMG-CoA Reductase Inhibitors (Statins)
- Inhibitors of other enzymes
- Integrase Inhibitors
- Ion Channels - Antiepileptics and Anticonvulsants
- K+ Channels - Antiepileptics and Anticonvulsants
- Kinesin Inhibitors
- M2 Protein Inhibitors
- MAO - Antiepileptics and Anticonvulsants
- Metabolic and GI Pathology
- mGluR - Antiepileptics and Anticonvulsants
- Microtubule Polymerization/Depolymerization Inhibitors
- Muscarininc Acetylcholine Receptor Inhibitors
- Na+ Channels - Antiepileptics and Anticonvulsants
- nAChR - Antiepileptics and Anticonvulsants
- NCCT Inhibitors (Thiazide/Thiazide-like diuretics)
- Neuraminidase Inhibitors
- NKCC1 Inhibitors (Loop Diuretics)
- NMDA - Antiepileptics and Anticonvulsants
- NSAIDs: COX-1 Inhibitors
- NSAIDs: COX-2 Inhibitors
- Nucleoside and Nucleotide Analogs
- Opioid Receptors - Antiepileptics and Anticonvulsants
- Other Analogs
- Other Compounds
- Other DA Signaling - Analgesics
- Other DA Signaling - Anesthetic
- Other DA Signaling - Antidepressant
- Other DA Signaling - Antipsychotic
- Other DA Signaling - Anxiolytic
- Other DA Signaling - Cognition Enhancing
- Other DA Signaling - Neurodegenerative Diseases
- Other DA Signaling - Sedatives
- Other Diuretics
- Other Hormones and Modulators
- Other Ion Channels - Analgesics
- Other Ion Channels - Anesthetic
- Other Ion Channels - Antidepressant
- Other Ion Channels - Antiepileptics and Anticonvulsants
- Other Ion Channels - Antipsychotic
- Other Ion Channels - Anxiolytic
- Other Ion Channels - Cognition Enhancing
- Other Ion Channels - Sedatives
- Other Lipid-lowering Compounds
- Other Neurotransmitters
- Other NSAID
- Other Nucleic Acid Inhibitors
- Other Products
- Other Targets
- Other Therapies
- Others
- Others - Antibacterial
- Others - Antidiabetic
- Others - Antithrombotic
- Others - Cell Membrane Modifiers
- Others - Ergosterol Inhibitors
- Others - Other nucleic acid inhibitors
- Pharmaceutical Impurities and Derivatives
- Pharmaceutical Impurities and Derivatives
- Prostaglandin D Synthase Inhibitors
- Prostaglandin Synthetase - Analgesics
- Protease Inhibitors
- Protein synthesis Inhibitors
- Proton Pump Inhibitors
- Raf
- Renin Inhibitors
- Reverse Transcriptase Inhibitors
- Sedatives and Hypnotics
- Serine/Threonine Kinase Inhibitors
- Serotonin (5-HT3) Receptor Inhibitors
- Sex steroids and Modulators
- Sigma Receptors - Antiepileptics and Anticonvulsants
- sorafenib
- Steroids Hormones and Modulators
- sting ligand
- tetrandrine
- Therapies for Respiratory Diseases and Allergy Management
- Thrombin Inhibitors
- Thyroid Hormones and Modulators
- Topoisomerase Inhibitors
- TRP Channels - Antiepileptics and Anticonvulsants
- Tubulin Inhibitors
- Tyrosine Kinase Inhibitors
- vemurafenib
- Viral Fusion and Entry Inhibitors
- β-Glucan Synthase Inhibitors (echinocandins)
- β-lactamase inhibitors
Product Matches
- Dabrafenib and Other Raf InhibitorsRaf proteins are serine/threonine kinases that transduce signals from Ras protei...
- D0005Dabrafenib Mesylate
B-Raf and c-Raf inhibitor.
≥98% - D0004Dabrafenib
B-Raf and c-Raf inhibitor.
≥98% - B242042BGB-283
Dual RAF/EGFR inhibitor.
≥98% - R0020RAF265
B-Raf, VEGFR2, c-Raf, PDGFR, CSF-1R, RET, c-Kit, Src, STE20 inhibitor.
≥98% - C104761CCT-196969
pan-Raf inhibitor.
≥98% - A9662AZ-628
B-Raf and c-Raf inhibitor.
≥96% - S0048Salicin
Alcoholic β-glucoside found in willow bark, salicylic acid prodrug; serine p...
≥98% - T0394(+)-Taxifolin
Catechol-type flavonoid; fatty acid synthesis inhibitor.
≥98% - M1847704-O-Methylhonokiol
Found in Magnolia officinalis.
≥98% - T0393(+/-)-Taxifolin Hydrate
Catechol-type flavonoid.
≥95% - B4248BKM120
PI3K inhibitor, microtubule polymerization inhibitor.
≥98% - B6902B-Raf IN 1
B-Raf and c-Raf inhibitor.
≥98% - B030966BAY 11-7082
inhibits inflammatory signaling
≥98% - P6002PP-121
p110α PI3K, DNA-PK, mTOR, Abl, Hck, Src, VEGFR2, PDGFR inhibitor.
≥98% - A6818Arenobufagin
Bufanolide steroid found in Bufo arenarum;VEGFR2 inhibitor, cardiovascular Na...
≥98% - D3322Diflunisal
NSAID; COX-1/2 inhibitor.
≥98% - Aromatase inhibitors may be an effective treatment for status epilepticusIn an animal study performed at Northwestern University in 2016, estrogen synthe...
- S5868Sorafenib
c-Raf, Ret, VEGFR2 inhibitor, potential STAT3/5 inhibitor, potential HMT inhi...
≥98% - S5869Sorafenib Tosylate
c-Raf, RET, VEGFR1 inhibitor, potential HMT inhibitor.
≥99%